aluates Reports

$ 0.0

Automative

Global Small Molecule Targeted Anti-cancer Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-35R2884

Global Small Molecule Targeted Anti cancer Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Global Small Molecule Targeted Anti-cancer Drug Market Research Report 2025

Code: QYRE-Auto-35R2884

Report

July 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Novartis

Millennium Pharmaceuticals

Bayer

Exelixis Inc

AbbVie

Boehringer Ingelheim

Eisai Co Ltd

Pfizer Inc

Bristol–Myers Squibb

Roche

Bettapharma

Small Molecule Targeted Anti-cancer Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Small Molecule Targeted Anti-cancer Drug Market

The global market for Small Molecule Targeted Anti-cancer Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Anti-cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Anti-cancer Drug.

The Small Molecule Targeted Anti-cancer Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Targeted Anti-cancer Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Small Molecule Targeted Anti-cancer Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Small Molecule Targeted Anti-cancer Drug Market Report

Report Metric	Details
Report Name	Small Molecule Targeted Anti-cancer Drug Market
CAGR	5%
Segment by Type	EGFR ALK Bcr-Abl Others
Segment by Application	Liver Cancer Colorectal Cancer Lung Cancer Gastric Cancer Breast Cancer Esophageal Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai, Pfizer, Bristol-Myers Squibb, Roche, Bettapharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Targeted Anti-cancer Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Small Molecule Targeted Anti-cancer Drug Market report?

Ans: The main players in the Small Molecule Targeted Anti-cancer Drug Market are Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai, Pfizer, Bristol-Myers Squibb, Roche, Bettapharma

What are the Application segmentation covered in the Small Molecule Targeted Anti-cancer Drug Market report?

Ans: The Applications covered in the Small Molecule Targeted Anti-cancer Drug Market report are Liver Cancer, Colorectal Cancer, Lung Cancer, Gastric Cancer, Breast Cancer, Esophageal Cancer, Others

What are the Type segmentation covered in the Small Molecule Targeted Anti-cancer Drug Market report?

Ans: The Types covered in the Small Molecule Targeted Anti-cancer Drug Market report are EGFR, ALK, Bcr-Abl, Others

Recommended Reports

Targeted Cancer Drugs

Broad Cancer Therapeutics

Cancer Diagnostics & Other Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 EGFR

1.2.3 ALK

1.2.4 Bcr-Abl

1.2.5 Others

1.3 Market by Application

1.3.1 Global Small Molecule Targeted Anti-cancer Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Liver Cancer

1.3.3 Colorectal Cancer

1.3.4 Lung Cancer

1.3.5 Gastric Cancer

1.3.6 Breast Cancer

1.3.7 Esophageal Cancer

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Molecule Targeted Anti-cancer Drug Market Perspective (2020-2031)

2.2 Global Small Molecule Targeted Anti-cancer Drug Growth Trends by Region

2.2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Small Molecule Targeted Anti-cancer Drug Historic Market Size by Region (2020-2025)

2.2.3 Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Region (2026-2031)

2.3 Small Molecule Targeted Anti-cancer Drug Market Dynamics

2.3.1 Small Molecule Targeted Anti-cancer Drug Industry Trends

2.3.2 Small Molecule Targeted Anti-cancer Drug Market Drivers

2.3.3 Small Molecule Targeted Anti-cancer Drug Market Challenges

2.3.4 Small Molecule Targeted Anti-cancer Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Small Molecule Targeted Anti-cancer Drug Players by Revenue

3.1.1 Global Top Small Molecule Targeted Anti-cancer Drug Players by Revenue (2020-2025)

3.1.2 Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Players (2020-2025)

3.2 Global Small Molecule Targeted Anti-cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Small Molecule Targeted Anti-cancer Drug Revenue

3.4 Global Small Molecule Targeted Anti-cancer Drug Market Concentration Ratio

3.4.1 Global Small Molecule Targeted Anti-cancer Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Anti-cancer Drug Revenue in 2024

3.5 Global Key Players of Small Molecule Targeted Anti-cancer Drug Head office and Area Served

3.6 Global Key Players of Small Molecule Targeted Anti-cancer Drug, Product and Application

3.7 Global Key Players of Small Molecule Targeted Anti-cancer Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Targeted Anti-cancer Drug Breakdown Data by Type

4.1 Global Small Molecule Targeted Anti-cancer Drug Historic Market Size by Type (2020-2025)

4.2 Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Type (2026-2031)

5 Small Molecule Targeted Anti-cancer Drug Breakdown Data by Application

5.1 Global Small Molecule Targeted Anti-cancer Drug Historic Market Size by Application (2020-2025)

5.2 Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Small Molecule Targeted Anti-cancer Drug Market Size (2020-2031)

6.2 North America Small Molecule Targeted Anti-cancer Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2020-2025)

6.4 North America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Small Molecule Targeted Anti-cancer Drug Market Size (2020-2031)

7.2 Europe Small Molecule Targeted Anti-cancer Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2020-2025)

7.4 Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size (2020-2031)

8.2 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Small Molecule Targeted Anti-cancer Drug Market Size (2020-2031)

9.2 Latin America Small Molecule Targeted Anti-cancer Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2020-2025)

9.4 Latin America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size (2020-2031)

10.2 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Astrazeneca

11.1.1 Astrazeneca Company Details

11.1.2 Astrazeneca Business Overview

11.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Introduction

11.1.4 Astrazeneca Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.1.5 Astrazeneca Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Introduction

11.2.4 Novartis Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Millennium Pharmaceuticals

11.3.1 Millennium Pharmaceuticals Company Details

11.3.2 Millennium Pharmaceuticals Business Overview

11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Introduction

11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.3.5 Millennium Pharmaceuticals Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Introduction

11.4.4 Bayer Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Exelixis

11.5.1 Exelixis Company Details

11.5.2 Exelixis Business Overview

11.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Introduction

11.5.4 Exelixis Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.5.5 Exelixis Recent Development

11.6 Abbvie

11.6.1 Abbvie Company Details

11.6.2 Abbvie Business Overview

11.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Introduction

11.6.4 Abbvie Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.6.5 Abbvie Recent Development

11.7 Boehringer-Ingelheim

11.7.1 Boehringer-Ingelheim Company Details

11.7.2 Boehringer-Ingelheim Business Overview

11.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Introduction

11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.7.5 Boehringer-Ingelheim Recent Development

11.8 Eisai

11.8.1 Eisai Company Details

11.8.2 Eisai Business Overview

11.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Introduction

11.8.4 Eisai Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.8.5 Eisai Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Introduction

11.9.4 Pfizer Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.9.5 Pfizer Recent Development

11.10 Bristol-Myers Squibb

11.10.1 Bristol-Myers Squibb Company Details

11.10.2 Bristol-Myers Squibb Business Overview

11.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Introduction

11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.10.5 Bristol-Myers Squibb Recent Development

11.11 Roche

11.11.1 Roche Company Details

11.11.2 Roche Business Overview

11.11.3 Roche Small Molecule Targeted Anti-cancer Drug Introduction

11.11.4 Roche Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.11.5 Roche Recent Development

11.12 Bettapharma

11.12.1 Bettapharma Company Details

11.12.2 Bettapharma Business Overview

11.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Introduction

11.12.4 Bettapharma Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

11.12.5 Bettapharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Novartis

Millennium Pharmaceuticals

Bayer

Exelixis Inc

AbbVie

Boehringer Ingelheim

Eisai Co Ltd

Pfizer Inc

Bristol–Myers Squibb

Roche

Bettapharma

List of Tables

Table 1. Global Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of EGFR

Table 3. Key Players of ALK

Table 4. Key Players of Bcr-Abl

Table 5. Key Players of Others

Table 6. Global Small Molecule Targeted Anti-cancer Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Small Molecule Targeted Anti-cancer Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Small Molecule Targeted Anti-cancer Drug Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Small Molecule Targeted Anti-cancer Drug Market Share by Region (2020-2025)

Table 10. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Small Molecule Targeted Anti-cancer Drug Market Share by Region (2026-2031)

Table 12. Small Molecule Targeted Anti-cancer Drug Market Trends

Table 13. Small Molecule Targeted Anti-cancer Drug Market Drivers

Table 14. Small Molecule Targeted Anti-cancer Drug Market Challenges

Table 15. Small Molecule Targeted Anti-cancer Drug Market Restraints

Table 16. Global Small Molecule Targeted Anti-cancer Drug Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Small Molecule Targeted Anti-cancer Drug Market Share by Players (2020-2025)

Table 18. Global Top Small Molecule Targeted Anti-cancer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Anti-cancer Drug as of 2024)

Table 19. Ranking of Global Top Small Molecule Targeted Anti-cancer Drug Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Small Molecule Targeted Anti-cancer Drug Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Small Molecule Targeted Anti-cancer Drug, Headquarters and Area Served

Table 22. Global Key Players of Small Molecule Targeted Anti-cancer Drug, Product and Application

Table 23. Global Key Players of Small Molecule Targeted Anti-cancer Drug, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Small Molecule Targeted Anti-cancer Drug Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2020-2025)

Table 27. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2026-2031)

Table 29. Global Small Molecule Targeted Anti-cancer Drug Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2020-2025)

Table 31. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2026-2031)

Table 33. North America Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Small Molecule Targeted Anti-cancer Drug Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Small Molecule Targeted Anti-cancer Drug Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size by Country (2026-2031) & (US$ Million)

Table 48. Astrazeneca Company Details

Table 49. Astrazeneca Business Overview

Table 50. Astrazeneca Small Molecule Targeted Anti-cancer Drug Product

Table 51. Astrazeneca Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 52. Astrazeneca Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Small Molecule Targeted Anti-cancer Drug Product

Table 56. Novartis Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. Millennium Pharmaceuticals Company Details

Table 59. Millennium Pharmaceuticals Business Overview

Table 60. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Product

Table 61. Millennium Pharmaceuticals Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 62. Millennium Pharmaceuticals Recent Development

Table 63. Bayer Company Details

Table 64. Bayer Business Overview

Table 65. Bayer Small Molecule Targeted Anti-cancer Drug Product

Table 66. Bayer Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 67. Bayer Recent Development

Table 68. Exelixis Company Details

Table 69. Exelixis Business Overview

Table 70. Exelixis Small Molecule Targeted Anti-cancer Drug Product

Table 71. Exelixis Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 72. Exelixis Recent Development

Table 73. Abbvie Company Details

Table 74. Abbvie Business Overview

Table 75. Abbvie Small Molecule Targeted Anti-cancer Drug Product

Table 76. Abbvie Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 77. Abbvie Recent Development

Table 78. Boehringer-Ingelheim Company Details

Table 79. Boehringer-Ingelheim Business Overview

Table 80. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Product

Table 81. Boehringer-Ingelheim Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 82. Boehringer-Ingelheim Recent Development

Table 83. Eisai Company Details

Table 84. Eisai Business Overview

Table 85. Eisai Small Molecule Targeted Anti-cancer Drug Product

Table 86. Eisai Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 87. Eisai Recent Development

Table 88. Pfizer Company Details

Table 89. Pfizer Business Overview

Table 90. Pfizer Small Molecule Targeted Anti-cancer Drug Product

Table 91. Pfizer Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 92. Pfizer Recent Development

Table 93. Bristol-Myers Squibb Company Details

Table 94. Bristol-Myers Squibb Business Overview

Table 95. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Product

Table 96. Bristol-Myers Squibb Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 97. Bristol-Myers Squibb Recent Development

Table 98. Roche Company Details

Table 99. Roche Business Overview

Table 100. Roche Small Molecule Targeted Anti-cancer Drug Product

Table 101. Roche Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 102. Roche Recent Development

Table 103. Bettapharma Company Details

Table 104. Bettapharma Business Overview

Table 105. Bettapharma Small Molecule Targeted Anti-cancer Drug Product

Table 106. Bettapharma Revenue in Small Molecule Targeted Anti-cancer Drug Business (2020-2025) & (US$ Million)

Table 107. Bettapharma Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Small Molecule Targeted Anti-cancer Drug Picture

Figure 2. Global Small Molecule Targeted Anti-cancer Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Small Molecule Targeted Anti-cancer Drug Market Share by Type: 2024 VS 2031

Figure 4. EGFR Features

Figure 5. ALK Features

Figure 6. Bcr-Abl Features

Figure 7. Others Features

Figure 8. Global Small Molecule Targeted Anti-cancer Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Small Molecule Targeted Anti-cancer Drug Market Share by Application: 2024 VS 2031

Figure 10. Liver Cancer Case Studies

Figure 11. Colorectal Cancer Case Studies

Figure 12. Lung Cancer Case Studies

Figure 13. Gastric Cancer Case Studies

Figure 14. Breast Cancer Case Studies

Figure 15. Esophageal Cancer Case Studies

Figure 16. Others Case Studies

Figure 17. Small Molecule Targeted Anti-cancer Drug Report Years Considered

Figure 18. Global Small Molecule Targeted Anti-cancer Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Small Molecule Targeted Anti-cancer Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Small Molecule Targeted Anti-cancer Drug Market Share by Region: 2024 VS 2031

Figure 21. Global Small Molecule Targeted Anti-cancer Drug Market Share by Players in 2024

Figure 22. Global Top Small Molecule Targeted Anti-cancer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Anti-cancer Drug as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Small Molecule Targeted Anti-cancer Drug Revenue in 2024

Figure 24. North America Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Small Molecule Targeted Anti-cancer Drug Market Share by Country (2020-2031)

Figure 26. United States Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Small Molecule Targeted Anti-cancer Drug Market Share by Country (2020-2031)

Figure 30. Germany Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Market Share by Region (2020-2031)

Figure 38. China Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Small Molecule Targeted Anti-cancer Drug Market Share by Country (2020-2031)

Figure 46. Mexico Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Small Molecule Targeted Anti-cancer Drug Market Share by Country (2020-2031)

Figure 50. Turkey Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Small Molecule Targeted Anti-cancer Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Astrazeneca Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 55. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 56. Bayer Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 57. Exelixis Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 58. Abbvie Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 59. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 60. Eisai Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 61. Pfizer Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 63. Roche Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 64. Bettapharma Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Small Molecule Anti tumor Targted Drug Market Insights Forecast to 2030

Global Small Molecule Cancer Drug Market Research Report 2025

Global Small Molecule Targeted Cancer Therapy Market Research Report 2025

Global Small Molecule Targted Drug Market Insights Forecast to 2030

Innovative Small Molecule Targeted Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti tumor Drug Market Research Report 2025

Global Commercialized Small Molecule for Therapy Market Research Report 2024

Small Molecule Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ovarian Cancer Drugs Market Insights Forecast to 2030

Global Targeted Drugs for Breast Cancer Market Research Report 2024

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA Targeted Small Molecule Drugs Market Research Report 2025

Targeted Drugs for Colorectal Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Synthetic Small Molecule API Market Insights Forecast to 2030

Global Anticancer Injection Market Research Report 2024

Cancer Growth Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drugs for NSCLC Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions